In vitro activities in new oxazolidinone antimicrobial agents against enterococci.
about
Determining Linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national release.Mode of action of Ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomesClinical experience with linezolid in the treatment of resistant gram-positive infectionsTelavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogensVancomycin-resistant enterococci.Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections.Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studiesAntibacterial agents that inhibit two-component signal transduction systems.A critical review of oxazolidinones: an alternative or replacement for glycopeptides and streptogramins?Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents.Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium.In vitro activity of the new oxazolidinone AZD2563 against EnterococciBreakthrough bacteremia by linezolid-susceptible Enterococcus faecalis under linezolid treatment in a severe polytrauma patient.
P2860
Q24535971-D026CB9A-ADBB-4875-9C62-A1D3AE4A8DBEQ24650162-17904577-14D3-48F2-9BD1-FCA238A79251Q28363047-94DAA995-8E26-4C77-BC8B-F42FA0BA7F81Q33788308-2AF9085D-05B9-477E-89DC-2CEDF247ED83Q33975592-9BEEB262-A109-43D6-8FE7-96411CEF5443Q33981016-1209D2B9-83F9-4EE4-B631-CE88012B13AFQ35013856-8A520599-BDFB-431A-8799-6ECB91A4D0C9Q36069845-68DAF9A2-C431-4327-9D10-CC8C89E45043Q36170448-06B89AFC-CC7B-470E-930A-3FE27377FEB7Q36548106-85CF10EE-A6A2-4439-9E0F-5B71C1522EDAQ39472331-9B68FEFB-1FD6-4B3E-8FBD-7175FF291FC2Q39658094-8C06B68F-238F-4CA2-A970-183BB624D99EQ42872187-A58FE3AC-230E-4023-A291-7B816276FB3B
P2860
In vitro activities in new oxazolidinone antimicrobial agents against enterococci.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
In vitro activities in new oxazolidinone antimicrobial agents against enterococci.
@ast
In vitro activities in new oxazolidinone antimicrobial agents against enterococci.
@en
type
label
In vitro activities in new oxazolidinone antimicrobial agents against enterococci.
@ast
In vitro activities in new oxazolidinone antimicrobial agents against enterococci.
@en
prefLabel
In vitro activities in new oxazolidinone antimicrobial agents against enterococci.
@ast
In vitro activities in new oxazolidinone antimicrobial agents against enterococci.
@en
P2093
P2860
P1476
In vitro activities in new oxazolidinone antimicrobial agents against enterococci.
@en
P2093
Eliopoulos GM
Moellering RC Jr
Wennersten CB
P2860
P304
P407
P577
1996-07-01T00:00:00Z